Phytochemical Screening and Evaluation of Cytotoxicity and Thrombolytic Properties of Achyranthes Aspera Leaf Extract
暂无分享,去创建一个
[1] S. Dhinesh,et al. Anticataract and antioxidant activities of Achyranthes aspera Linn.against glucose-induced cataractogenesis using goat lenses , 2012 .
[2] M. I. Zuberi,et al. Invasive alien species in Northern Bangladesh: Identification, inventory and impacts , 2009 .
[3] R. Varatharajan,et al. Anti-inflammatory activity of roots of Achyranthes aspera , 2009 .
[4] R. Ilavarasan,et al. Phytochemicals investigation on a tropical plant, Syzygium cumini from Kattuppalayam, Erode District, Tamil Nadu, South India. , 2009 .
[5] M. Balasubramanian,et al. Experimental Studies of Achyranthes aspera (L) Preventing Nephrotoxicity Induced by Lead in Albino Rats , 2009 .
[6] G. Ayoola,et al. Phytochemical Screening and Antioxidant Activities of Some Selected Medicinal Plants Used for Malaria Therapy in Southwestern Nigeria , 2008 .
[7] R. Kashyap,et al. Effect of Fagonia Arabica (Dhamasa) on in vitro thrombolysis , 2007, BMC complementary and alternative medicine.
[8] Amit Bardia,et al. A history of streptokinase use in acute myocardial infarction. , 2007, Texas Heart Institute journal.
[9] I. Ahmad,et al. Antioxidant and Free Radical Scavenging Properties of Twelve Traditionally Used Indian Medicinal Plants , 2006 .
[10] L. Maes,et al. Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. , 2006, Journal of ethnopharmacology.
[11] R. Chakrabarti,et al. Achyranthes aspera stimulates the immunity and enhances the antigen clearance in Catla catla. , 2006, International immunopharmacology.
[12] Marcy J. Balunas,et al. Drug discovery from medicinal plants. , 2005, Life sciences.
[13] D. E. Okwu,et al. Phytochemical constituents of some Nigerian medicinal plants , 2005 .
[14] R. Scofield,et al. Achyranthes aspera (Amaranthaceae) a new indigenous addition to the flora of the Kermadec Islands group , 2004 .
[15] P. Cozzi,et al. Recent anticancer cytotoxic agents. , 2004, Current medicinal chemistry. Anti-cancer agents.
[16] H. Nishino,et al. Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. , 2002, Cancer letters.
[17] M. Richardson. Biopharmacologic and herbal therapies for cancer: research update from NCCAM. , 2001, The Journal of nutrition.
[18] J. Hsu,et al. Coiled Coil Region of Streptokinase γ-Domain Is Essential for Plasminogen Activation* , 2001, The Journal of Biological Chemistry.
[19] D. E. Okwu. Evaluation of The Chemical Composition of Indigenous Spices and Flavouring Agents , 2001 .
[20] A. Kar,et al. Achyranthes aspera elevates thyroid hormone levels and decreases hepatic lipid peroxidation in male rats. , 2000, Journal of ethnopharmacology.
[21] M. Verstraete,et al. Third-generation thrombolytic drugs. , 2000, The American journal of medicine.
[22] F. Leighton,et al. Plant polyphenol antioxidants and oxidative stress. , 2000, Biological research.
[23] H. Rupprecht,et al. Antithrombotic therapy in acute coronary syndromes. , 2000, EXS.
[24] Y. Gaillard,et al. Poisoning by plant material: review of human cases and analytical determination of main toxins by high-performance liquid chromatography-(tandem) mass spectrometry. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[25] Murray H. G. Munro,et al. Evolving Strategies for the Selection, Dereplication and Prioritization of Antitumor and HIV-Inhibitory Natural Products Extracts , 1999 .
[26] J. McLaughlin,et al. The Use of Biological Assays to Evaluate Botanicals , 1998 .
[27] K. Wood,et al. Five novel mono-tetrahydrofuran ring acetogenins from the seeds of Annona muricata. , 1996, Journal of natural products.
[28] H. Lee. How Safe is the Readministration of Streptokinase? , 1995, Drug safety.
[29] P. Turner. Clinical Pharmacology, seventh edition , 1993 .
[30] D. Grahame-Smith. Clinical pharmacology. Seventh edition , 1993 .
[31] W. Nichols,et al. Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue-plasminogen activator. , 1992, Journal of the American College of Cardiology.
[32] R. Chander,et al. Hypolipidemic activity of Achyranthus aspera Linn in normal and triton induced hyperlipemic rats. , 1992, Indian journal of experimental biology.
[33] D. E. Nichols,et al. Brine shrimp: a convenient general bioassay for active plant constituents. , 1982, Planta medica.
[34] J. Harborne. Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis , 1973 .
[35] R. Garg,et al. Preliminary pharmacological studies on achyranthine. , 1970 .